Cargando…
In Vitro/In Vivo Evaluation of Clomipramine Orodispersible Tablets for the Treatment of Depression and Obsessive-Compulsive Disorder
The first and only antidepressant drug on the market with solid proof of clinically significant serotonin and noradrenaline reuptake inhibition is clomipramine (CLP). However, significant first-pass metabolism reduces its absorption to less than 62%. It is heavily protein-bound and broadly dispersed...
Autores principales: | Ghumman, Shazia Akram, Hameed, Huma, Noreen, Sobia, Al-Hussain, Sami A., Kausar, Rizwana, Irfan, Ali, Shabbir, Ramla, Rana, Maria, Amanat, Amina, Zaki, Magdi E. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967651/ https://www.ncbi.nlm.nih.gov/pubmed/37259410 http://dx.doi.org/10.3390/ph16020265 |
Ejemplares similares
-
CLOMIPRAMINE IN RESISTANT OBSESSIVE COMPULSIVE DISORDER
por: Khanna, Sumant, et al.
Publicado: (1988) -
OBSESSIVE COMPULSIVE NEUROSIS : CLOMIPRAMINE, PROLACTIN AND THERAPEUTIC RESPONSE
por: Ananth, Jambur, et al.
Publicado: (1997) -
Intravenous Clomipramine for Treatment-Resistant Obsessive-Compulsive Disorder
por: Karameh, Wael Karameh, et al.
Publicado: (2015) -
Mimosa pudica mucilage nanoparticles of losartan potassium: Characterization and pharmacodynamics evaluation
por: Ghumman, Shazia Akram, et al.
Publicado: (2023) -
Synthesis of pH-Sensitive Cross-Linked Basil Seed Gum/Acrylic Acid Hydrogels by Free Radical Copolymerization Technique for Sustained Delivery of Captopril
por: Ghumman, Shazia Akram, et al.
Publicado: (2022)